CNE100003PR1
CNE100003PR1
BRIGHTGENE BIO-MEDICAL TECHNOLO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.223.640.130 | 1.282.551.615 | 4.6% |
| Cost of Revenue | 601.611.553 | 544.950.816 | 10.4% |
| Gross Profit | 622.028.577 | 737.600.799 | 15.7% |
| 511.830.473 | 486.773.378 | 5.1% | |
| Operating Income | 110.198.103 | 250.827.421 | 56.1% |
| Pretax Income | 13.908.831 | 157.200.608 | 91.2% |
| Net Income Common Stockholders | 54.514.681 | 189.166.937 | 71.2% |
| -- | -- | -- | |
| -- | -- | -- |